Dawn Mattoon - Nov 4, 2021 Form 4 Insider Report for Quanterix Corp (QTRX)

Role
Sr. VP, Diagnostics
Signature
/s/ Brian Keane, as Attorney-in-Fact
Stock symbol
QTRX
Transactions as of
Nov 4, 2021
Transactions value $
-$283,980
Form type
4
Date filed
11/8/2021, 03:26 PM
Previous filing
Nov 4, 2021
Next filing
Dec 3, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QTRX Common Stock Sale -$57 -1 0% $57.00 36.5K Nov 4, 2021 Direct F1
transaction QTRX Common Stock Options Exercise $205K +10.7K +29.35% $19.12 47.2K Nov 5, 2021 Direct F2
transaction QTRX Common Stock Sale -$477K -8.34K -17.65% $57.25 38.9K Nov 5, 2021 Direct F1, F2, F3
transaction QTRX Common Stock Sale -$11.7K -200 -0.51% $58.39 38.7K Nov 5, 2021 Direct F1, F2, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QTRX Stock Option (right to buy) Options Exercise $0 -10.7K -50.38% $0.00 10.6K Nov 5, 2021 Common Stock 10.7K $19.12 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted on March 15, 2021.
F2 Includes 13,966 restricted stock units.
F3 This transaction was executed in multiple trades at prices ranging from $57.00 to $57.975. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F4 This transaction was executed in multiple trades at prices ranging from $58.35 to $58.435.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F5 The option vests as to 25% of the shares on May 10, 2019 and vests as to an additional 2.083% of the shares per month for 36 months thereafter.